ETFs
R
REGN
Regeneron Pharmaceuticals
834.04
+7.40+0.90%After Hours: 838.10 +4.06 +0.49%19:58 08/21 EDT
OPEN/PREV CLOSE835.74/826.64
TODAY RANGE826.64-847.00
VOL786.92K
MARKET CAP85.87B
52 WEEK RANGE538.24-847.00
AVG VOL (3M)939.50K
% TURNOVER0.75%
TURNOVER--
P/E (TTM)20.62
% RANGE2.45%
EPS(TTM)40.45
P/E(FORWARD)19.31
P/B2.720
BVPS306.69
DIVIDEND3.760
P/S6.15
BETA--
DIV YIELD0.45%
FREE FLOAT MKT CAP82.54B
SHARES OUTSTANDING102.95M
NEXT EARNINGS10/26-10/30
FREE FLOAT98.96M
LOT SIZE1
EX-DATE08/18/2026
News
Press Releases
Financial Reports
Profile
Simply Wall St·14h ago
Does First-in-Class FOP Drug Approval Transform the Bull Case For Regeneron Pharmaceuticals (REGN)?
Simply Wall St·2d ago
Regeneron Pharmaceuticals (REGN) Wins Pasatru Approval, Is The Upside Already Priced In?
Seeking Alpha·3d ago
Alvotech: Reiterate Hold On AVT05/AVT06 BLA Resubmissions And Upcoming Catalysts
Simply Wall St·3d ago
Regeneron Pharmaceuticals (REGN) Wins FDA Approval For The First Adult FOP Treatment
TipRanks·3d ago
Private Markets: $1B for Base Power, $545M for Whatnot
TipRanks·3d ago
Regeneron (REGN) Gets a Hold from Scotiabank
TipRanks·3d ago
Regeneron’s Pasatru granted FDA approval for FOP
Benzinga·3d ago
Bill Ackman Donates $400 Million in Pershing Square Stock to Build a Research Institute After His Daughter’s Severe Brain Hemorrhage
Same Industry